Mammary carcinoma behavior is programmed in the precancer stem cell

Breast Cancer Research

Volumn 10, Issue 3, 2008, Pages

  Damonte, Patrizia ^a   Hodgson, J Graeme ^b   Chen, Jane Q ^a   Young, Lawrence J T ^a   Cardiff, Robert D ^a   Borowsky, Alexander D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; TELOMERASE;

ANIMAL; ARTICLE; CANCER STEM CELL; CANCER TRANSPLANTATION; CYTOLOGY; DISEASE COURSE; EXPERIMENTAL NEOPLASM; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECANCER; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICROSATELLITE REPEATS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TELOMERASE;

EID: 55749087187     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2104     Document Type: Article

References (27)

1. Page DL, Dupont WD. Premalignant conditions and markers of elevated risk in the breast and their management. Surg Clin North Am 1990, 70:831-851. 2371647.
2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312:146-151. 3965932.
3. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982, 49:751-758. 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y, 6275978.
4. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004, 350:1430-1441. 10.1056/NEJMra031301, 15070793.
5. Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg 2003, 90:426-432. 10.1002/bjs.4051, 12673743.
6. Medina D, DeOme KB, Young L. Tumor-producing capabilities of hyperplastic alveolar nodules in virgin and hormone-stimulated BALB/c f. C3H and C3Hf mice. J Natl Cancer Inst 1970, 44:167-174.
7. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001, 61:8298-8305.
8. Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther 2004, 3:941-953.
9. Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL, Gregg JP. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol Cancer Res 2004, 2:453-463. 15328372.
10. Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Heterogeneity of mammary lesions represent molecular differences. BMC Cancer 2006, 6:275. 1762020, 17147824, 10.1186/1471-2407-6-275.
11. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells: perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006, 66:9339-9344. 10.1158/0008-5472.CAN-06-3126, 16990346.
12. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004, 432:338-341. 10.1038/nature03099, 15549096.
13. Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005, 22:47-59. 10.1007/s10585-005-2908-5, 16132578.
14. Abbey CK, Borowsky AD, McGoldrick ET, Gregg JP, Maglione JE, Cardiff RD, Cherry SR. In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci USA 2004, 101:11438-11443. 509219, 15277673, 10.1073/pnas.0404396101.
15. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K, Miranda M, Krig S, Garbe J, Stampfer M, Yaswen P, Gray JW, Lockett SJ. In situ analyses of genome instability in breast cancer. Nat Genet 2004, 36:984-988. 10.1038/ng1409, 15300252.
16. Tsao JL, Tavare S, Salovaara R, Jass JR, Aaltonen LA, Shibata D. Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am J Pathol 1999, 154:1815-1824. 2222548, 10362806.
17. Sontag L, Axelrod DE. Evaluation of pathways for progression of heterogeneous breast tumors. J Theor Biol 2005, 232:179-189. 10.1016/j.jtbi.2004.08.002, 15530488.
18. Borowsky A. Special considerations in mouse models of breast cancer. Breast Dis 2007, 28:29-38.
19. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J. Hormone dependence in premalignant mammary progression. Cancer Res 2003, 63:1067-1072.
20. Artandi SE. Complex roles for telomeres and telomerase in breast carcinogenesis. Breast Cancer Res 2003, 5:37-41. 154132, 12559044, 10.1186/bcr553.
21. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, Castrillon DH, Horner JW, Weiler SR, Carrasco RD, DePinho RA. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 2002, 99:8191-8196. 123043, 12034875, 10.1073/pnas.112515399.
22. Daniel CW, De Ome KB, Young JT, Blair PB, Faulkin LJ. The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc Natl Acad Sci USA 1968, 61:53-60. 285904, 4301594, 10.1073/pnas.61.1.53.
23. Chadeneau C, Siegel P, Harley CB, Muller WJ, Bacchetti S. Telomerase activity in normal and malignant murine tissues. Oncogene 1995, 11:893-898.
24. Huang EH, Heidt DG, Li CW, Simeone DM. Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 2007, 141:415-419. 10.1016/j.surg.2006.12.015, 17383517.
25. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88. 10.1038/nature04372, 16397499.
26. Smith GH. Functional differentiation of virgin mouse mammary epithelium in explant culture is dependent upon extracellular proline. J Cell Physiol 1987, 131:190-199. 10.1002/jcp.1041310208, 3034921.
27. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005, 132:681-687. 10.1242/dev.01609, 15647322.